USPTO serial 79044961
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes, Chemicals for use in industry, Chemicals used in industry, Chemicals used in the manufacture of fabric or textiles, Cleaning agents and cleaning agents in tablet form for industrial use; unprocessed artificial resins, unprocessed plastics; soil fertilizers; fire extinguishing compositions; tempering and soldering preparations; chemical preparations for preserving foodstuffs; adhesives used in industry; descaling agents and descaling agents in tablet form, other than for household use | SECTION 71 - CANCELLED | — |
| 003 | Dental bleaching gel, Tooth bleaching preparations, Laundry bleach, Laundry blueing, Laundry detergent, Laundry detergents, Laundry pre-soak, Laundry sizing, Laundry soap, Laundry starch; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices; descaling agents and descaling agents in tablet form for household use; cleaning agents and cleaning agents in tablet form | SECTION 71 - CANCELLED | — |
| 005 | Almond oil for pharmaceutical purposes, Almond oils for pharmaceutical purposes, Antibacterial pharmaceuticals, Anti-diabetic pharmaceuticals, Cardiovascular pharmaceuticals, Dermatological pharmaceutical products, Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, Homeopathic pharmaceuticals for use in the treatment of various diseases and conditions, Pharmaceutical antitussive-cold preparations, Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of various diseases, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for use in urology, Pharmaceutical preparations for the treatment of eye diseases and conditions, Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, Pharmaceutical preparations for skin care, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical products for the treatment of joint disease, Pharmaceuticals for the treatment of erectile dysfunction, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives, Amino acids for medical or veterinary purposes, Anti-infective products for veterinary use, Bacterial and bacteriological preparations for medical or veterinary purposes, Bacteriostats for medicinal, dental and veterinary use, Biochemical preparations for medical or veterinary purposes, Plant extracts for medical, veterinary and pharmaceutical purposes, Veterinary preparations, namely, pain relief medication, Veterinary preparations for treatment of intestinal bacteria, Veterinary preparations for various animal conditions, Veterinary preparations, namely, antioxidants, Dietic foods adapted for medical use; Diet capsules, Diet pills, Food for medically restricted diets; medical plasters; all purpose disinfectants; Gastrointestinal cleaning agents; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic foods; food for babies; medical plasters; material for stopping teeth and dental wax; preparations for destroying vermin; fungicides; herbicides; nutritional supplements and effervescent tablets for pharmaceutical use | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 2, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Mar 2, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 10, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 1, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 1, 2016 | INPC | INVALIDATION PROCESSED | — |
| Dec 24, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 24, 2015 | C71T | CANCELLED SECTION 71 | — |
| May 18, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 8, 2011 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 4, 2009 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 14, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 14, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 24, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 23, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 8, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 18, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| May 30, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 29, 2008 | ALIE | ASSIGNED TO LIE | — |
| May 29, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 26, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 24, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 24, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 22, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 22, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 22, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 14, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 26, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 26, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 24, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 23, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 15, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |